Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
Few reports have suggested that nulliparous young patients with endometrial cancer may be treated conservatively to preserve fertility. We present a young nulliparous woman with a well differentiated adenocarcinoma of the endometrium treated with progestins. Since she did not respond, a definite operation was performed revealing involvement of the uterine isthmus, thus necessitating adjuvant radiotherapy.
Vinker
S
S
Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel. vinker@intemet-zahav.net
Shani
A
A
Open
M
M
Fenig
E
E
Dgani
R
R
D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D016889:Endometrial Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D007044:Hysterectomy; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D009361:Neoplasm Invasiveness; D010052:Ovariectomy; D010298:Parity; D011085:Polycystic Ovary Syndrome / Q000150:complications; D018714:Radiotherapy, Adjuvant
D018931:Antineoplastic Agents, Hormonal; D017258:Medroxyprogesterone Acetate